Soluble Therapeutics is a biotechnology startup that offers a pioneering technology, the HSC™ Technology, aimed at enhancing the protein-based drug discovery process. The company was founded in 2008 and operates in the Biotechnology, Health Care, and Pharmaceutical industries. With its rapid optimization of solubility and stability, Soluble Therapeutics is revolutionizing the world of protein-based pharmaceuticals, vaccines, and therapeutics. Their innovative approach addresses a critical need in the industry, promising to significantly improve the efficiency and success rate of drug discovery processes. While details about the last investment and the investors are currently not available, Soluble Therapeutics demonstrates considerable potential for growth and impact within the biotech sector.
There is no investment information
No recent news or press coverage available for Soluble Therapeutics.